Current position:Home >Product >
2-phenoxyethyl (6S)-6-(4-ethylphenyl)-3-methyl-4-oxidanylidene-1,5,6,7-tetrahydroindole-2-carboxylate
2-phenoxyethyl (6S)-6-(4-ethylphenyl)-3-methyl-4-oxidanylidene-1,5,6,7-tetrahydroindole-2-carboxylate
|
|
Canonical SMILES:
CCC1=CC=C(C=C1)C2CC3=C(C(=C(N3)C(=O)OCCOC4=CC=CC=C4)C)C(=O)C2
Isomeric SMILES
CCC1=CC=C(C=C1)[C@H]2CC3=C(C(=C(N3)C(=O)OCCOC4=CC=CC=C4)C)C(=O)C2
InChI
InChI=1S/C26H27NO4/c1-3-18-9-11-19(12-10-18)20-15-22-24(23(28)16-20)17(2)25(27-22)26(29)31-14-13-30-21-7-5-4-6-8-21/h4-12,20,27H,3,13-16H2,1-2H3/t20-/m0/s1
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- 1-[(2S)-4-[(3-methoxyphenyl)methyl]-2-methyl-piperazin-4-ium-1-yl]-2-(1-methylbenzimidazol-2-yl)sulfanyl-ethanone
- 1-[(2S)-4-[(3-methoxyphenyl)methyl]-2-methyl-piperazin-1-yl]-2-(1-methylbenzimidazol-2-yl)sulfanyl-ethanone
- 2-methoxyethyl (6R)-6-(4-chlorophenyl)-3-methyl-4-oxidanylidene-1,5,6,7-tetrahydroindole-2-carboxylate
- ethyl (4S)-4-(2-methoxyphenyl)-6-[(1-methylimidazol-2-yl)sulfanylmethyl]-2-oxidanylidene-3,4-dihydro-1H-pyrimidine-5-carboxylate
- methyl (4R)-4-(3,4-dimethoxyphenyl)-6-[(1-methylimidazol-2-yl)sulfanylmethyl]-2-oxidanylidene-3,4-dihydro-1H-pyrimidine-5-carboxylate
- cyclohexylmethyl (6R)-6-(4-chlorophenyl)-3-methyl-4-oxidanylidene-1,5,6,7-tetrahydroindole-2-carboxylate
- [(2R)-oxolan-2-yl]methyl (6S)-6-(4-ethylphenyl)-3-methyl-4-oxidanylidene-1,5,6,7-tetrahydroindole-2-carboxylate
- diethyl-[3-[[(3R)-1-(1-ethylbenzimidazol-2-yl)piperidin-3-yl]carbonylamino]propyl]azanium
- (3R)-N-[3-(diethylamino)propyl]-1-(1-ethylbenzimidazol-2-yl)piperidine-3-carboxamide
- methyl (4R)-4-(3-methoxyphenyl)-6-[(1-methylimidazol-2-yl)sulfanylmethyl]-2-oxidanylidene-3,4-dihydro-1H-pyrimidine-5-carboxylate

